Drug interactions for the following drug(s)
Applies to: Potassium Chloride 8 MEQ Extended Release Oral Capsule <> Amiodarone hydrochloride 200 MG Oral Tablet
Potassium chloride may increase the hyperkalemic activities of Amiodarone.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Potassium Chloride 8 MEQ Extended Release Oral Capsule
Carbidopa may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Pantoprazole may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The excretion of Valproic acid can be decreased when combined with Pantoprazole.
Applies to: Escitalopram 10 MG Oral Tablet <> Amiodarone hydrochloride 200 MG Oral Tablet
The serum concentration of Amiodarone can be increased when it is combined with Escitalopram.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Folic Acid 1 MG Oral Tablet
Folic acid may decrease the excretion rate of Carbidopa which could result in a higher serum level.
Applies to: Folic Acid 1 MG Oral Tablet <> pantoprazole 40 MG Delayed Release Oral Tablet
Pantoprazole may decrease the excretion rate of Folic acid which could result in a higher serum level.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Amiodarone hydrochloride 200 MG Oral Tablet
The risk or severity of hypotension and orthostatic hypotension can be increased when Amiodarone is combined with Levodopa.
Applies to: gabapentin 600 MG Oral Tablet <> pantoprazole 40 MG Delayed Release Oral Tablet
Pantoprazole may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
Applies to: Memantine hydrochloride 10 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The metabolism of Valproic acid can be decreased when combined with Memantine.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
Pantoprazole may decrease the excretion rate of Donepezil which could result in a higher serum level.
Applies to: Memantine hydrochloride 10 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Memantine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Applies to: Escitalopram 10 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
The metabolism of Escitalopram can be decreased when combined with Memantine.
Applies to: Potassium Chloride 8 MEQ Extended Release Oral Capsule <> Escitalopram 10 MG Oral Tablet
The risk or severity of gastrointestinal ulceration can be increased when Escitalopram is combined with Potassium chloride.
Applies to: Potassium Chloride 8 MEQ Extended Release Oral Capsule <> Memantine hydrochloride 10 MG Oral Tablet
Potassium chloride may decrease the excretion rate of Memantine which could result in a higher serum level.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
The risk or severity of adverse effects can be increased when Donepezil is combined with Levodopa.
Applies to: Folic Acid 1 MG Oral Tablet <> gabapentin 600 MG Oral Tablet
Folic acid may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
Applies to: Folic Acid 1 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The serum concentration of Folic acid can be decreased when it is combined with Valproic acid.
Applies to: Escitalopram 10 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
The risk or severity of bleeding can be increased when Escitalopram is combined with Rivaroxaban.
Applies to: gabapentin 600 MG Oral Tablet <> Potassium Chloride 8 MEQ Extended Release Oral Capsule
Potassium chloride may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
Applies to: Folic Acid 1 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Folic acid may decrease the excretion rate of Memantine which could result in a higher serum level.
Applies to: Levonorgestrel 1.5 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The metabolism of Levonorgestrel can be increased when combined with Valproic acid.
Applies to: gabapentin 600 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The risk or severity of adverse effects can be increased when Valproic acid is combined with Gabapentin.
Applies to: Amiodarone hydrochloride 200 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The metabolism of Amiodarone can be decreased when combined with Valproic acid.
Applies to: divalproex sodium 500 MG 24 HR Extended Release Oral Tablet <> rivaroxaban 15 MG Oral Tablet
The metabolism of Rivaroxaban can be decreased when combined with Valproic acid.
Applies to: gabapentin 600 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Rivaroxaban may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Escitalopram 10 MG Oral Tablet
The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Levodopa.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Pantoprazole may decrease the excretion rate of Memantine which could result in a higher serum level.
Applies to: gabapentin 600 MG Oral Tablet <> gabapentin 600 MG Oral Tablet
The risk or severity of adverse effects can be increased when Gabapentin is combined with Gabapentin enacarbil.
Applies to: Amiodarone hydrochloride 200 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
The serum concentration of Rivaroxaban can be increased when it is combined with Amiodarone.
Applies to: Escitalopram 10 MG Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
The therapeutic efficacy of Escitalopram can be decreased when used in combination with Donepezil.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> gabapentin 600 MG Oral Tablet
The risk or severity of adverse effects can be increased when Levodopa is combined with Gabapentin enacarbil.
Applies to: Levonorgestrel 1.5 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Levonorgestrel.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Carbidopa may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Applies to: gabapentin 600 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Memantine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.
Applies to: gabapentin 600 MG Oral Tablet <> Escitalopram 10 MG Oral Tablet
The risk or severity of adverse effects can be increased when Gabapentin is combined with Escitalopram.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Carbidopa may decrease the excretion rate of Memantine which could result in a higher serum level.
Applies to: Fludrocortisone 0.1 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
The therapeutic efficacy of Memantine can be decreased when used in combination with Fludrocortisone.
Applies to: Escitalopram 10 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Escitalopram.
Applies to: Fludrocortisone 0.1 MG Oral Tablet <> Levonorgestrel 1.5 MG Oral Tablet
The serum concentration of Fludrocortisone can be increased when it is combined with Levonorgestrel.
Applies to: Donepezil hydrochloride 10 MG Disintegrating Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The metabolism of Valproic acid can be decreased when combined with Donepezil.
Applies to: Amiodarone hydrochloride 200 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
The serum concentration of Memantine can be increased when it is combined with Amiodarone.
Applies to: Folic Acid 1 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Folic acid may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Applies to: gabapentin 600 MG Oral Tablet <> Levonorgestrel 1.5 MG Oral Tablet
The metabolism of Gabapentin can be increased when combined with Levonorgestrel.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> pantoprazole 40 MG Delayed Release Oral Tablet
Carbidopa may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Applies to: gabapentin 600 MG Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
The risk or severity of adverse effects can be increased when Donepezil is combined with Gabapentin enacarbil.
Applies to: Potassium Chloride 8 MEQ Extended Release Oral Capsule <> rivaroxaban 15 MG Oral Tablet
Potassium chloride may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Applies to: Fludrocortisone 0.1 MG Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
The therapeutic efficacy of Donepezil can be decreased when used in combination with Fludrocortisone.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> Escitalopram 10 MG Oral Tablet
The metabolism of Escitalopram can be decreased when combined with Pantoprazole.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
The risk or severity of adverse effects can be increased when Valproic acid is combined with Levodopa.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> Potassium Chloride 8 MEQ Extended Release Oral Capsule
Pantoprazole may decrease the excretion rate of Potassium chloride which could result in a higher serum level.
Applies to: Amiodarone hydrochloride 200 MG Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
The metabolism of Amiodarone can be decreased when combined with Donepezil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: Potassium Chloride 8 MEQ Extended Release Oral Capsule <> Amiodarone hydrochloride 200 MG Oral Tablet
Drug1 (rxcui = 315183, name = potassium chloride 8 MEQ Extended Release Oral Capsule, tty = SCD). Drug2 (rxcui = 833528, name = amiodarone hydrochloride 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to amiodarone, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Amiodarone and Potassium chloride.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Potassium Chloride 8 MEQ Extended Release Oral Capsule
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 315183, name = potassium chloride 8 MEQ Extended Release Oral Capsule, tty = SCD). Drug1 is resolved to carbidopa, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Carbidopa and Potassium chloride. Drug1 is resolved to potassium chloride, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Potassium chloride and Carbidopa.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to pantoprazole, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Pantoprazole and Rivaroxaban.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to valproic acid, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Valproic acid and Pantoprazole. Drug1 is resolved to valproate, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Valproic acid and Pantoprazole.
Applies to: Escitalopram 10 MG Oral Tablet <> Amiodarone hydrochloride 200 MG Oral Tablet
Drug1 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 833528, name = amiodarone hydrochloride 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to amiodarone, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Amiodarone and Escitalopram.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Folic Acid 1 MG Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310410, name = folic acid 1 MG Oral Tablet, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Folic acid and Carbidopa. Drug1 is resolved to carbidopa, Drug2 is resolved to folic acid and interaction asserted in DrugBank between Carbidopa and Folic acid.
Applies to: Folic Acid 1 MG Oral Tablet <> pantoprazole 40 MG Delayed Release Oral Tablet
Drug1 (rxcui = 310410, name = folic acid 1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Folic acid and Pantoprazole.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Amiodarone hydrochloride 200 MG Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 833528, name = amiodarone hydrochloride 200 MG Oral Tablet, tty = SCD). Drug1 is resolved to amiodarone, Drug2 is resolved to levodopa and interaction asserted in DrugBank between Amiodarone and Levodopa.
Applies to: gabapentin 600 MG Oral Tablet <> pantoprazole 40 MG Delayed Release Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to pantoprazole, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Pantoprazole and Gabapentin enacarbil.
Applies to: Memantine hydrochloride 10 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to memantine, Drug2 is resolved to valproate and interaction asserted in DrugBank between Memantine and Valproic acid. Drug1 is resolved to memantine, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Memantine and Valproic acid.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
Drug1 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 997220, name = donepezil hydrochloride 10 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to pantoprazole, Drug2 is resolved to donepezil and interaction asserted in DrugBank between Pantoprazole and Donepezil.
Applies to: Memantine hydrochloride 10 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to memantine, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Memantine and Rivaroxaban.
Applies to: Escitalopram 10 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to memantine, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Memantine and Escitalopram.
Applies to: Potassium Chloride 8 MEQ Extended Release Oral Capsule <> Escitalopram 10 MG Oral Tablet
Drug1 (rxcui = 315183, name = potassium chloride 8 MEQ Extended Release Oral Capsule, tty = SCD). Drug2 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to potassium chloride, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Potassium chloride and Escitalopram.
Applies to: Potassium Chloride 8 MEQ Extended Release Oral Capsule <> Memantine hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 315183, name = potassium chloride 8 MEQ Extended Release Oral Capsule, tty = SCD). Drug2 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to memantine, Drug2 is resolved to potassium chloride and interaction asserted in DrugBank between Memantine and Potassium chloride.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 997220, name = donepezil hydrochloride 10 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to donepezil and interaction asserted in DrugBank between Levodopa and Donepezil.
Applies to: Folic Acid 1 MG Oral Tablet <> gabapentin 600 MG Oral Tablet
Drug1 (rxcui = 310410, name = folic acid 1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Folic acid and Gabapentin enacarbil.
Applies to: Folic Acid 1 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 310410, name = folic acid 1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to valproate and interaction asserted in DrugBank between Folic acid and Valproic acid. Drug1 is resolved to folic acid, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Folic acid and Valproic acid.
Applies to: Escitalopram 10 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to escitalopram, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Escitalopram and Rivaroxaban.
Applies to: gabapentin 600 MG Oral Tablet <> Potassium Chloride 8 MEQ Extended Release Oral Capsule
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 315183, name = potassium chloride 8 MEQ Extended Release Oral Capsule, tty = SCD). Drug1 is resolved to potassium chloride, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Potassium chloride and Gabapentin enacarbil.
Applies to: Folic Acid 1 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 310410, name = folic acid 1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to memantine and interaction asserted in DrugBank between Folic acid and Memantine.
Applies to: Levonorgestrel 1.5 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 483325, name = levonorgestrel 1.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to levonorgestrel, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Levonorgestrel and Valproic acid. Drug1 is resolved to levonorgestrel, Drug2 is resolved to valproate and interaction asserted in DrugBank between Levonorgestrel and Valproic acid.
Applies to: gabapentin 600 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to valproic acid, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Valproic acid and Gabapentin. Drug1 is resolved to valproate, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Valproic acid and Gabapentin enacarbil. Drug1 is resolved to gabapentin, Drug2 is resolved to valproate and interaction asserted in DrugBank between Gabapentin and Valproic acid. Drug1 is resolved to valproic acid, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Valproic acid and Gabapentin enacarbil.
Applies to: Amiodarone hydrochloride 200 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 833528, name = amiodarone hydrochloride 200 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to amiodarone, Drug2 is resolved to valproate and interaction asserted in DrugBank between Amiodarone and Valproic acid. Drug1 is resolved to amiodarone, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Amiodarone and Valproic acid.
Applies to: divalproex sodium 500 MG 24 HR Extended Release Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to valproate, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Valproic acid and Rivaroxaban. Drug1 is resolved to valproic acid, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Valproic acid and Rivaroxaban.
Applies to: gabapentin 600 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Gabapentin enacarbil and Rivaroxaban.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Escitalopram 10 MG Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Levodopa and Escitalopram.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to memantine, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Memantine and Pantoprazole.
Applies to: gabapentin 600 MG Oral Tablet <> gabapentin 600 MG Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin enacarbil and Gabapentin.
Applies to: Amiodarone hydrochloride 200 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 833528, name = amiodarone hydrochloride 200 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to amiodarone, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Amiodarone and Rivaroxaban.
Applies to: Escitalopram 10 MG Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
Drug1 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 997220, name = donepezil hydrochloride 10 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to donepezil, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Donepezil and Escitalopram.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> gabapentin 600 MG Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Levodopa and Gabapentin enacarbil. Drug1 is resolved to carbidopa, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Carbidopa and Gabapentin enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Gabapentin enacarbil and Carbidopa. Drug1 is resolved to levodopa, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Levodopa and Gabapentin.
Applies to: Levonorgestrel 1.5 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 483325, name = levonorgestrel 1.5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to levonorgestrel, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Levonorgestrel and Rivaroxaban.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to rivaroxaban, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Rivaroxaban and Carbidopa. Drug1 is resolved to carbidopa, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Carbidopa and Rivaroxaban.
Applies to: gabapentin 600 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to memantine, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Memantine and Gabapentin enacarbil.
Applies to: gabapentin 600 MG Oral Tablet <> Escitalopram 10 MG Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Gabapentin and Escitalopram. Drug1 is resolved to escitalopram, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Escitalopram and Gabapentin enacarbil.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to memantine, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Memantine and Carbidopa. Drug1 is resolved to carbidopa, Drug2 is resolved to memantine and interaction asserted in DrugBank between Carbidopa and Memantine.
Applies to: Fludrocortisone 0.1 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 313979, name = fludrocortisone acetate 0.1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to fludrocortisone, Drug2 is resolved to memantine and interaction asserted in DrugBank between Fludrocortisone and Memantine.
Applies to: Escitalopram 10 MG Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to valproate, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Valproic acid and Escitalopram. Drug1 is resolved to valproic acid, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Valproic acid and Escitalopram.
Applies to: Fludrocortisone 0.1 MG Oral Tablet <> Levonorgestrel 1.5 MG Oral Tablet
Drug1 (rxcui = 313979, name = fludrocortisone acetate 0.1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483325, name = levonorgestrel 1.5 MG Oral Tablet, tty = SCD). Drug1 is resolved to fludrocortisone, Drug2 is resolved to levonorgestrel and interaction asserted in DrugBank between Fludrocortisone and Levonorgestrel.
Applies to: Donepezil hydrochloride 10 MG Disintegrating Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 997220, name = donepezil hydrochloride 10 MG Disintegrating Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to valproic acid, Drug2 is resolved to donepezil and interaction asserted in DrugBank between Valproic acid and Donepezil. Drug1 is resolved to valproate, Drug2 is resolved to donepezil and interaction asserted in DrugBank between Valproic acid and Donepezil.
Applies to: Amiodarone hydrochloride 200 MG Oral Tablet <> Memantine hydrochloride 10 MG Oral Tablet
Drug1 (rxcui = 833528, name = amiodarone hydrochloride 200 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 996561, name = memantine hydrochloride 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to amiodarone, Drug2 is resolved to memantine and interaction asserted in DrugBank between Amiodarone and Memantine.
Applies to: Folic Acid 1 MG Oral Tablet <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 310410, name = folic acid 1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to folic acid, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Folic acid and Rivaroxaban.
Applies to: gabapentin 600 MG Oral Tablet <> Levonorgestrel 1.5 MG Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483325, name = levonorgestrel 1.5 MG Oral Tablet, tty = SCD). Drug1 is resolved to levonorgestrel, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Levonorgestrel and Gabapentin.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> pantoprazole 40 MG Delayed Release Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to carbidopa, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Carbidopa and Pantoprazole. Drug1 is resolved to pantoprazole, Drug2 is resolved to carbidopa anhydrous and interaction asserted in DrugBank between Pantoprazole and Carbidopa.
Applies to: gabapentin 600 MG Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
Drug1 (rxcui = 310433, name = gabapentin 600 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 997220, name = donepezil hydrochloride 10 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to donepezil, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Donepezil and Gabapentin enacarbil. Drug1 is resolved to gabapentin, Drug2 is resolved to donepezil and interaction asserted in DrugBank between Gabapentin and Donepezil.
Applies to: Potassium Chloride 8 MEQ Extended Release Oral Capsule <> rivaroxaban 15 MG Oral Tablet
Drug1 (rxcui = 315183, name = potassium chloride 8 MEQ Extended Release Oral Capsule, tty = SCD). Drug2 (rxcui = 1232082, name = rivaroxaban 15 MG Oral Tablet, tty = SCD). Drug1 is resolved to potassium chloride, Drug2 is resolved to rivaroxaban and interaction asserted in DrugBank between Potassium chloride and Rivaroxaban.
Applies to: Fludrocortisone 0.1 MG Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
Drug1 (rxcui = 313979, name = fludrocortisone acetate 0.1 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 997220, name = donepezil hydrochloride 10 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to fludrocortisone, Drug2 is resolved to donepezil and interaction asserted in DrugBank between Fludrocortisone and Donepezil.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> Escitalopram 10 MG Oral Tablet
Drug1 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 349332, name = escitalopram 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to pantoprazole, Drug2 is resolved to escitalopram and interaction asserted in DrugBank between Pantoprazole and Escitalopram.
Applies to: Carbidopa 25 MG / L-DOPA 100 MG Extended Release Oral Tablet <> divalproex sodium 500 MG 24 HR Extended Release Oral Tablet
Drug1 (rxcui = 308988, name = carbidopa 25 MG / levodopa 100 MG Extended Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1099569, name = 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, tty = SCD). Drug1 is resolved to levodopa, Drug2 is resolved to valproic acid and interaction asserted in DrugBank between Levodopa and Valproic acid. Drug1 is resolved to levodopa, Drug2 is resolved to valproate and interaction asserted in DrugBank between Levodopa and Valproic acid.
Applies to: pantoprazole 40 MG Delayed Release Oral Tablet <> Potassium Chloride 8 MEQ Extended Release Oral Capsule
Drug1 (rxcui = 314200, name = pantoprazole 40 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 315183, name = potassium chloride 8 MEQ Extended Release Oral Capsule, tty = SCD). Drug1 is resolved to potassium chloride, Drug2 is resolved to pantoprazole and interaction asserted in DrugBank between Potassium chloride and Pantoprazole.
Applies to: Amiodarone hydrochloride 200 MG Oral Tablet <> Donepezil hydrochloride 10 MG Disintegrating Oral Tablet
Drug1 (rxcui = 833528, name = amiodarone hydrochloride 200 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 997220, name = donepezil hydrochloride 10 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to amiodarone, Drug2 is resolved to donepezil and interaction asserted in DrugBank between Amiodarone and Donepezil.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.